Thioredoxin suppresses the contact hypersensitivity response by inhibiting leukocyte recruitment during the elicitation phase

Antioxidants and Redox Signaling

Volumn 11, Issue 6, 2009, Pages 1227-1235

  Fukunaga, Atsushi ^a,b   Horikawa, Tatsuya ^a   Ogura, Kanako ^a   Taguchi, Kumiko ^a   Yu, Xijun ^a   Funasaka, Yoko ^a   Takeda, Masafumi ^b   Nakamura, Hajime ^c   Yodoi, Junji ^d   Nishigori, Chikako ^a  

^a Division of Dermatology   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Department of Experimental Therapeutics

^d KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CROTON OIL; HAPTEN; THIOREDOXIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUSAL ATTRIBUTION; CELL MIGRATION; CELL PROLIFERATION; CONTACT DERMATITIS; CONTROLLED STUDY; DENDRITIC CELL; DONOR; DRUG BLOOD LEVEL; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; FEMALE; HOST; IMMUNOSUPPRESSIVE TREATMENT; INHIBITION KINETICS; LEUKOCYTE FUNCTION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; DERMATITIS, ALLERGIC CONTACT; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; FEMALE; LEUKOCYTES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; THIOREDOXINS;

ANIMALIA; MUS MUSCULUS;

EID: 65349182384     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2008.2340     Document Type: Article

References (37)

1. Bertini R, Howard OM, Dong HF, Oppenheim JJ, Bizzarri C, Sergi R, Caselli G, Pagliei S, Romines B, Wilshire JA, Mengozzi M, Nakamura H, Yodoi J, Pekkari K, Gurunath R, Holmgren A, Herzenberg LA, Herzenberg LA, and Ghezzi P. Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutro-phils, monocytes, and T cells. J Exγ Med 189: 1783-1789, 1999.
2. Dilulio NA, Engeman T, Armstrong D, Tannenbaum C, Hamilton TA, and Fairchild RL. Groalpha-mediated recruitment of neutrophils is required for elicitation of contact hypersensitivity. Eur J Immunol 29: 3485-3495, 1999.
3. Engeman T, Gorbachev AV, Kish DD, and Fairchild RL. The intensity of neutrophil infiltration controls the number of antigen-primed CD8 T cells recruited into cutaneous antigen challenge sites. J Leukoc Biol 76: 941-949, 2004.
4. Fuchs J, Zollner TM, Kaufmann R, and Podda M. Redox-modulated pathways in inflammatory skin diseases. Free Radic Biol Med 30: 337-353, 2001.
5. Fukunaga A, Nagai H, Noguchi T, Okazawa H, Matozaki T, Yu X, Lagenaur CF, Honma N, Ichihashi M, Kasuga M, Nishigori C, and Horikawa T. Src homology 2 domain-containing protein tyrosine phosphatase substrate 1 regulates the migration of Langerhans cells from the epidermis to draining lymph nodes. J Immunol 172: 4091-4099, 2004.
6. Fukunaga A, Nagai H, Yu X, Qniki S, Okazawa H, Motegi S, Suzuki R, Honma N, Matozaki T, Nishigori C, and Horikawa T. Src homology 2 domain-containing protein tyrosine phosphatase substrate 1 regulates the induction of Langerhans cell maturation. Eur J Immunol 36: 3216-3226, 2006.
7. Gocinski BL and Tigelaar RE. Roles of CD4+ and CD8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J Immunol 144: 4121-4128,1990.
8. He D, Wu L, Kim HK, Li H, Elmets CA, and Xu H. CD8+ IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses. J Immunol 177: 6852-6858, 2006.
9. Holmgren A. Thioredoxin. Annu Rev Biochem 54: 237-271, 1985.
10. Holmgren A. Thioredoxin and glutaredoxin systems. J Biol Chem 264: 13963-13966, 1989.
11. Hoshino T, Nakamura H, Okamoto M, Kato S, Araya S, Nomiyama K, Oizumi K, Young HA, Aizawa H, and Yodoi J. Redox-active protein thioredoxin prevents proinflammatory cytokine- or bleomycin-induced lung injury. Am J Respir Crit Care Med 168: 1075-1083, 2003.
12. Ichiki H, Hoshino T, Kinoshita T, Imaoka H, Kato S, Inoue H, Nakamura H, Yodoi J, Young HA, and Aizawa H. Thioredoxin suppresses airway hyperresponsiveness and airway inflammation in asthma. Biochem Bioγhys Res Com-mun 334: 1141-1148, 2005.
13. Kabashima K, Shiraishi N, Sugita K, Mori T, Qnoue A, Kobayashi M, Sakabe J, Yoshiki R, Tamamura H, Fujii N, Inaba K, and Tokura Y. CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells. Am J Pathol 171: 1249-1257, 2007.
14. Kaplan DH, Jenison MC, Saeland S, Shlomchik WD, and Shlomchik MJ. Epidermal Langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 23: 611-620, 2005.
15. Kissenpfennig A, Henri S, Dubois B, Laplace-Builhe C, Perrin P, Romani N, Tripp CH, Douillard P, Leserman L, Kaiserlian D, Saeland S, Davoust J, and Malissen B. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22: 643-654, 2005.
16. Kurimoto C, Kawano S, Tsuji G, Hatachi S, Jikimoto T, Sugiyama D, Kasagi S, Komori T, Nakamura H, Yodoi J, and Kumagai S. Thioredoxin may exert a protective effect against tissue damage caused by oxidative stress in salivary glands of patients with Sjogren's syndrome. J Rheumatol 34: 2035-2043, 2007.
17. Lange RW, Germolec DR, Foley JF, and Luster MI. Anti-oxidants attenuate anthralin-induced skin inflammation in BALB/c mice: role of specific proinflammatory cytokines. J Leukoc Biol 64: 170-176, 1998.
18. Laurent TC, Moore EC, and Reichard P. Enzymatic synthesis of deoxyribonucleotides, IV: isolation and characterization of thioredoxin, the hydrogen donor from Escherichia coli B. J Biol Chem 239: 3436-3444, 1964.
19. Matsue H, Edelbaum D, Shalhevet D, Mizumoto N, Yang C, Mummert ME, Oeda J, Masayasu H, and Takashima A. Generation and function of reactive oxygen species in dendritic cells during antigen presentation. J Immunol 171: 3010-3018, 2003.
20. Miyachi Y, Uchida K, Komura J, Asada Y, and Niwa Y. Auto-oxidative damage in cement dermatitis. Arch Dermatol Res 277: 288-292, 1985.
21. Mizuashi M, Ohtani T, Nakagawa S, and Aiba S. Redox imbalance induced by contact sensitizers triggers the maturation of dendritic cells. J Invest Dermatol 124: 579-586, 2005.
22. Mizumoto N, Kumamoto T, Robson SC, Sevigny J, Matsue H, Enjyoji K, and Takashima A. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat Med 8: 358-365, 2002.
23. Na K, Kim KE, Park ST, and Kim TY. EC-SOD suppresses contact hypersensitivity in mouse skin by impairing Langerhans cell migration. J Invest Dermatol 127: 1930-1937, 2007.
24. Nakamura H, De Rosa S, Roederer M, Anderson MT, Dubs JG, Yodoi J, Holmgren A, and Herzenberg LA. Elevation of plasma thioredoxin levels in HIV-infected individuals. Int Immunol 8: 603-611, 1996.
25. Nakamura H, Herzenberg LA, Bai J, Araya S, Kondo N, Nishinaka Y, Herzenberg LA, and Yodoi J. Circulating thioredoxin suppresses lipopolysaccharide-induced neutro-phil chemotaxis. Proc Natl Acad Sci U S A 98: 15143-15148, 2001.
26. Nakamura H, Masutani H, and Yodoi J. Extracellular thioredoxin and thioredoxin-binding protein 2 in control of cancer. Semin Cancer Biol 16: 444-451, 2006.
27. Okuyama H, Nakamura H, Shimahara Y, Uyama N, Kwon YW, Kawada N, Yamaoka Y, and Yodoi J. Overexpression of thioredoxin prevents thioacetamide-induced hepatic fibrosis in mice. J Heγatol 42: 117-123, 2005.
28. Rutault K, Alderman C, Chain BM, and Katz DR. Reactive oxygen species activate human peripheral blood dendritic cells. Free Radic Biol Med 26: 232-238, 1999.
29. Senaldi G, Pointaire P, Piguet PF, and Grau GE. Protective effect of N-acetylcysteine in hapten-induced irritant and contact hypersensitivity reactions. J Invest Dermatol 102: 934-937, 1994.
30. Tagaya Y, Maeda Y, Mitsui A, Kondo N, Matsui H, Hamuro J, Brown N, Arai K, Yokota T, Wakasugi H, and Yodoi J. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin: possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J 8: 757-764, 1989.
31. Takagi Y, Mitsui A, Nishiyama A, Nozaki K, Sono H, Gon Y, Hashimoto N, and Yodoi J. Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proc Natl Acad Sci U S A 96: 4131-4136, 1999.
32. Tamaki H, Nakamura H, Nishio A, Nakase H, Ueno S, Uza N, Kido M, Inoue S, Mikami S, Asada M, Kiriya K, Kitamura H, Ohashi S, Fukui T, Kawasaki K, Matsuura M, Ishii Y, Okazaki K, Yodoi J, and Chiba T. Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production. Gas-troenterology 131: 1110-1121, 2006.
33. Toews GB, Bergstresser PR, and Streilein JW. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J Immunol 124: 445-453, 1980.
34. Tsuji G, Koshiba M, Nakamura H, Kosaka H, Hatachi S, Kurimoto C, Kurosaka M, Hayashi Y, Yodoi J, and Kumagai S. Thioredoxin protects against joint destruction in a murine arthritis model. Free Radic Biol Med 40: 1721-1731, 2006.
35. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P, Oliver P, Huang W, Zhang P, Zhang J, Shellito JE, Bagby GJ, Nelson S, Charrier K, Peschon JJ, and Kolls JK. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194: 519-527, 2001.
36. Yokozeki H, Ghoreishi M, Takagawa S, Takayama K, Satoh T, Katayama I, Takeda K, Akira S, and Nishioka K. Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity. J Exp Med 191: 995-1004, 2000.
37. Yu X, Fukunaga A, Nagai H, Oniki S, Honma N, Ichihashi M, Matozaki T, Nishigori C, and Horikawa T. Engagement of CD47 inhibits the contact hypersensitivity response via the suppression of motility and B7 expression by Langer-hans cells. J Invest Dermatol 126: 797-807, 2006.